Annual Non Current Assets
$1.64 B
+$729.20 M+79.68%
31 December 2023
Summary:
Neurocrine Biosciences annual long term assets is currently $1.64 billion, with the most recent change of +$729.20 million (+79.68%) on 31 December 2023. During the last 3 years, it has risen by +$925.90 million (+128.87%). NBIX annual non current assets is now at all-time high.NBIX Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$1.66 B
+$23.20 M+1.42%
30 September 2024
Summary:
Neurocrine Biosciences quarterly long term assets is currently $1.66 billion, with the most recent change of +$23.20 million (+1.42%) on 30 September 2024. Over the past year, it has increased by +$460.10 million (+38.40%). NBIX quarterly non current assets is now -0.90% below its all-time high of $1.67 billion, reached on 31 March 2024.NBIX Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBIX Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +79.7% | +38.4% |
| 3 y3 years | +128.9% | +63.9% |
| 5 y5 years | +543.9% | +359.8% |
NBIX Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +128.9% | -0.9% | +81.2% |
| 5 y | 5 years | at high | +543.9% | -0.9% | +379.7% |
| alltime | all time | at high | >+9999.0% | -0.9% | >+9999.0% |
Neurocrine Biosciences Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.66 B(+1.4%) |
| June 2024 | - | $1.64 B(-2.3%) |
| Mar 2024 | - | $1.67 B(+1.8%) |
| Dec 2023 | $1.61 B(+10.6%) | $1.64 B(+37.2%) |
| Sept 2023 | - | $1.20 B(+7.3%) |
| June 2023 | - | $1.12 B(+20.4%) |
| Mar 2023 | - | $927.00 M(+1.3%) |
| Dec 2022 | $1.45 B(+49.4%) | $915.20 M(-2.4%) |
| Sept 2022 | - | $937.90 M(-4.9%) |
| June 2022 | - | $986.40 M(-12.4%) |
| Mar 2022 | - | $1.13 B(+2.4%) |
| Dec 2021 | $972.80 M(-4.3%) | $1.10 B(+8.7%) |
| Sept 2021 | - | $1.01 B(+19.5%) |
| June 2021 | - | $846.30 M(+11.2%) |
| Mar 2021 | - | $761.00 M(+5.9%) |
| Dec 2020 | $1.02 B(+22.3%) | $718.50 M(+107.8%) |
| Sept 2020 | - | $345.70 M(-6.4%) |
| June 2020 | - | $369.40 M(-6.2%) |
| Mar 2020 | - | $393.70 M(-17.1%) |
| Dec 2019 | $831.00 M(+12.6%) | $475.00 M(+31.7%) |
| Sept 2019 | - | $360.70 M(+13.4%) |
| June 2019 | - | $318.05 M(-2.0%) |
| Mar 2019 | - | $324.53 M(+27.1%) |
| Dec 2018 | $737.78 M(+33.0%) | $255.37 M(+16.4%) |
| Sept 2018 | - | $219.35 M(-19.8%) |
| June 2018 | - | $273.64 M(-6.5%) |
| Mar 2018 | - | $292.64 M(+11.4%) |
| Dec 2017 | $554.92 M(+78.8%) | $262.67 M(+17.3%) |
| Sept 2017 | - | $224.01 M(+3.1%) |
| June 2017 | - | $217.34 M(+335.4%) |
| Mar 2017 | - | $49.91 M(-8.7%) |
| Dec 2016 | $310.44 M(-19.2%) | $54.64 M(+32.4%) |
| Sept 2016 | - | $41.27 M(+9.0%) |
| June 2016 | - | $37.87 M(-35.1%) |
| Mar 2016 | - | $58.35 M(-35.7%) |
| Dec 2015 | $384.07 M(+93.8%) | $90.71 M(-17.3%) |
| Sept 2015 | - | $109.65 M(-10.0%) |
| June 2015 | - | $121.79 M(-0.8%) |
| Mar 2015 | - | $122.83 M(+174.0%) |
| Dec 2014 | $198.20 M(+33.5%) | $44.83 M(-39.3%) |
| Sept 2014 | - | $73.88 M(+2.7%) |
| June 2014 | - | $71.96 M(+25.0%) |
| Mar 2014 | - | $57.56 M(+826.3%) |
| Dec 2013 | $148.46 M(-21.6%) | $6.21 M(-7.9%) |
| Sept 2013 | - | $6.75 M(-64.4%) |
| June 2013 | - | $18.96 M(-19.4%) |
| Mar 2013 | - | $23.53 M(+250.4%) |
| Dec 2012 | $189.26 M(+42.9%) | $6.71 M(-55.9%) |
| Sept 2012 | - | $15.23 M(-26.9%) |
| June 2012 | - | $20.83 M(-17.2%) |
| Mar 2012 | - | $25.17 M(+327.1%) |
| Dec 2011 | $132.48 M(-0.4%) | $5.89 M(-54.3%) |
| Sept 2011 | - | $12.90 M(+75.1%) |
| June 2011 | - | $7.37 M(-0.6%) |
| Mar 2011 | - | $7.41 M(-34.8%) |
| Dec 2010 | $133.05 M | $11.37 M(-38.0%) |
| Sept 2010 | - | $18.34 M(+62.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2010 | - | $11.28 M(-2.3%) |
| Mar 2010 | - | $11.55 M(-25.1%) |
| Dec 2009 | $55.39 M(-32.0%) | $15.43 M(-12.9%) |
| Sept 2009 | - | $17.72 M(-46.4%) |
| June 2009 | - | $33.09 M(-2.2%) |
| Mar 2009 | - | $33.82 M(-8.0%) |
| Dec 2008 | $81.42 M(-55.5%) | $36.76 M(-66.3%) |
| Sept 2008 | - | $108.92 M(-2.8%) |
| June 2008 | - | $112.04 M(+22.2%) |
| Mar 2008 | - | $91.68 M(-2.2%) |
| Dec 2007 | $182.95 M(-5.5%) | $93.71 M(-50.5%) |
| Sept 2007 | - | $189.32 M(-1.0%) |
| June 2007 | - | $191.27 M(-1.1%) |
| Mar 2007 | - | $193.40 M(-1.3%) |
| Dec 2006 | $193.66 M(-30.7%) | $196.02 M(-1.7%) |
| Sept 2006 | - | $199.35 M(-1.3%) |
| June 2006 | - | $201.92 M(-0.4%) |
| Mar 2006 | - | $202.68 M(-0.6%) |
| Dec 2005 | $279.31 M(-11.0%) | $203.81 M(+0.2%) |
| Sept 2005 | - | $203.34 M(-0.3%) |
| June 2005 | - | $203.99 M(-0.7%) |
| Mar 2005 | - | $205.33 M(-0.0%) |
| Dec 2004 | $313.81 M(-33.5%) | $205.40 M(-4.9%) |
| Sept 2004 | - | $215.96 M(+2.6%) |
| June 2004 | - | $210.43 M(+7.6%) |
| Mar 2004 | - | $195.62 M(+135.3%) |
| Dec 2003 | $471.81 M(+90.2%) | $83.15 M(-5.5%) |
| Sept 2003 | - | $88.03 M(+50.6%) |
| June 2003 | - | $58.46 M(+175.3%) |
| Mar 2003 | - | $21.23 M(+15.1%) |
| Dec 2002 | $248.09 M(-25.2%) | $18.45 M(+5.2%) |
| Sept 2002 | - | $17.53 M(+4.5%) |
| June 2002 | - | $16.77 M(+14.2%) |
| Mar 2002 | - | $14.68 M(-1.1%) |
| Dec 2001 | $331.51 M(+92.3%) | $14.84 M(-2.9%) |
| Sept 2001 | - | $15.29 M(+3.4%) |
| June 2001 | - | $14.79 M(+6.0%) |
| Mar 2001 | - | $13.95 M(+2.9%) |
| Dec 2000 | $172.41 M(+81.9%) | $13.56 M(-0.6%) |
| Sept 2000 | - | $13.64 M(-7.9%) |
| June 2000 | - | $14.81 M(+3.0%) |
| Mar 2000 | - | $14.38 M(-0.1%) |
| Dec 1999 | $94.80 M(+44.5%) | $14.40 M(+2.1%) |
| Sept 1999 | - | $14.10 M(0.0%) |
| June 1999 | - | $14.10 M(-0.7%) |
| Mar 1999 | - | $14.20 M(-4.7%) |
| Dec 1998 | $65.60 M(-14.1%) | $14.90 M(-21.6%) |
| Sept 1998 | - | $19.00 M(+11.8%) |
| June 1998 | - | $17.00 M(+11.8%) |
| Mar 1998 | - | $15.20 M(-1.9%) |
| Dec 1997 | $76.40 M(+6.0%) | $15.50 M(+36.0%) |
| Sept 1997 | - | $11.40 M(0.0%) |
| June 1997 | - | $11.40 M(+72.7%) |
| Mar 1997 | - | $6.60 M(+11.9%) |
| Dec 1996 | $72.10 M | $5.90 M(0.0%) |
| Sept 1996 | - | $5.90 M(+18.0%) |
| June 1996 | - | $5.00 M(+19.0%) |
| Mar 1996 | - | $4.20 M |
FAQ
- What is Neurocrine Biosciences annual long term assets?
- What is the all time high annual non current assets for Neurocrine Biosciences?
- What is Neurocrine Biosciences annual non current assets year-on-year change?
- What is Neurocrine Biosciences quarterly long term assets?
- What is the all time high quarterly non current assets for Neurocrine Biosciences?
- What is Neurocrine Biosciences quarterly non current assets year-on-year change?
What is Neurocrine Biosciences annual long term assets?
The current annual non current assets of NBIX is $1.64 B
What is the all time high annual non current assets for Neurocrine Biosciences?
Neurocrine Biosciences all-time high annual long term assets is $1.64 B
What is Neurocrine Biosciences annual non current assets year-on-year change?
Over the past year, NBIX annual long term assets has changed by +$729.20 M (+79.68%)
What is Neurocrine Biosciences quarterly long term assets?
The current quarterly non current assets of NBIX is $1.66 B
What is the all time high quarterly non current assets for Neurocrine Biosciences?
Neurocrine Biosciences all-time high quarterly long term assets is $1.67 B
What is Neurocrine Biosciences quarterly non current assets year-on-year change?
Over the past year, NBIX quarterly long term assets has changed by +$460.10 M (+38.40%)